No Detail Found!

Effect of dexmedetomidine-induced sleep balance treatment on the chronic refractory primary insomnia patients.

Author(s)
Ma Guo-Zhong Department of Neurology Disease, Institute of Surgery Research, Daping Hospital, Third Military Medical University, Chongqing, China
Jiang Xiao-Jiang Department of Neurology Disease, Institute of Surgery Research, Daping Hospital, Third Military Medical University, Chongqing, China
Xu Zhi-Qiang Department of Neurology Disease, Institute of Surgery Research, Daping Hospital, Third Military Medical University, Chongqing, China
Lang Ying Department of Neurology, Institute of Surgery Research, Daping Hospital, Third Military Medical University, 10 Changjiang Branch Road, Yuzhong District, Chongqing, China
Li Xu-Jun Department of Neurology Disease, Institute of Surgery Research, Daping Hospital, Third Military Medical University, Chongqing, China
Chen Ni-Ka Department of Neurology Disease, Institute of Surgery Research, Daping Hospital, Third Military Medical University, Chongqing, China
Li Fa-Guo Department of Medical Psychology, Institute of Surgery Research, Daping Hospital, Third Military Medical University, Chongqing, China
Feng Zheng-Quan Department of Fifth Laboratory, Institute of Surgery Research, Daping Hospital, Third Military Medical University, Chongqing, China
Abstract
Aim: to pilot study the therapeutic effect of dexmedetomidine-induced sleep balance treatment (disbt) on the chronic refractory primary insomnia patients. Methods: forty-two patients with chronic refractory primary insomnia were randomly divided into two groups by random number table. Patients in disbt group were given disbt for 3 days, while patients in the control group were given conventional treatment for 3 day. Pittsburgh sleep quality index (psqi), the hyperarousal scale (has), and hamilton anxiety scale (hama) were evaluated and compared between the pre-treatment and post-1-week-treatment. Sleep architecture and electroencephalogram (eeg) spectrum were also recorded and compared pre-treatment and posttreatment. Results: the scores of psqi and hama in both groups after treatment were lower than those before treatment (p p p p p p p p p > 0.05), the extreme score, introspectiveness score, react score of has in disbt group after treatment were lower than those before treatment (p Conclusion: disbt effectively reduced the insomnia patient cortex hyperarousal level, corrected disorder of sleepawakening pathways and eased up insomnia symptom. It is an effective method for chronic refractory primary insomnia.
Publication Details
Page(s) 102-109
DOI DOI not available
Published Journal: Journal of Basic and Applied Sciences, Volume: 10, Issue: 0, Year: 2014

Request the full text from PASTIC

0

Citations

0

Downloads

108

Views